home / stock / htbx / htbx news


HTBX News and Press, Heat Biologics Inc. From 09/09/20

Stock Information

Company Name: Heat Biologics Inc.
Stock Symbol: HTBX
Market: NASDAQ
Website: heatbio.com

Menu

HTBX HTBX Quote HTBX Short HTBX News HTBX Articles HTBX Message Board
Get HTBX Alerts

News, Short Squeeze, Breakout and More Instantly...

HTBX - COVID-19 vaccine developers rally on AstraZeneca study pause

Many COVID-19 vaccine players are in the green premarket in apparent response to a potential safety signal in a Phase 3 study of AstraZeneca's (NYSE: AZN ) AZD1222. AZN is down  2%  on light volume. More news on: AstraZeneca PLC, Sanofi, GlaxoSmithKline plc, Healthcare stocks...

HTBX - 9 Reasons Why The Race For Major COVID-19 Vaccine Revenues Has Greatly Narrowed

One of my investments is in a small COVID vaccine company, Heat Biologics ( HTBX ), and I generally route for the little guy. So I don't particularly like writing an article that has a number of facts and reasons why probably none of the remaining small players are going to become major player...

HTBX - DOCU, CRWD among premarket gainers

Guess' (NYSE: GES ) +25%  on Q2 results . More news on: Guess', Inc., TSR, Inc., Vera Bradley, Inc., Stocks on the move, , Read more ...

HTBX - Heat Biologics nabs new U.S. patent covering gp96 platform

The USPTO has issued a new patent , No. 10,758,611, to Heat Biologics (NASDAQ: HTBX ) covering compositions of matter that are part of the company's gp96 platform in combination with a T cell costimulatory agonist in a single therapy. More news on: Heat Biologics, Inc., Healthcare stock...

HTBX - Heat Biologics Issued Key Patent on Combination Platform Therapy

Superior pre-clinical activity compared to conventional costimulatory antibody combination administered systemically DURHAM, NC / ACCESSWIRE / September 2, 2020 / Heat Biologics, Inc. ("Heat") (NASDAQ:HTBX) , a clinical-stage biopharmaceutical company focused on developing first-in-c...

HTBX - AstraZeneca starts U.S. final-stage trial of COVID-19 Vaccine

AstraZeneca (NYSE: AZN ) has expanded development of its COVID-19 vaccine AZD1222 into Phase III clinical trial in the U.S. to assess its safety, efficacy and immunogenicity. More news on: AstraZeneca PLC, Moderna, Inc., Pfizer Inc., Healthcare stocks news, Read more ...

HTBX - Has The COVID-19 Vaccine Stock Bubble Burst?

COVID-19 vaccine stocks have easily been the hottest niche across the entire market since March. Developmental-stage companies like Inovio Pharmaceuticals (NASDAQ: INO) , Moderna (NASDAQ: MRNA) , Novavax (NASDAQ: NVAX) , Vaxart (NASDAQ: VXRT) , and Heat Biologics (NASDAQ: HTBX) a...

HTBX - DLTR, BDX among premarket losers

Cocrystal Pharma (NASDAQ: COCP )   -25%  after raising "bought deal" offering to $15M. More news on: Cocrystal Pharma, Inc., SunPower Corporation, Quidel Corporation, Stocks on the move, , Read more ...

HTBX - Why Heat Biologics Stock Is Popping Today

Shares of the developmental biotech Heat Biologics (NASDAQ: HTBX) jumped by as much as 21% in pre-market trading Wednesday morning. The company's shares perked up in response to the release of a pre-print (a preliminary article that has yet to be peer-reviewed) discussing the animal data for...

HTBX - Stepped Up Clinical Efforts Targeting Breast Cancer Therapies and Treatments Leading to Opportunistic Options

August 26, 2020 Palm Beach, FL –August 26, 2020 – Although various market revenue projections may differ in the total dollar figures, the reports in the triple negative breast cancer (TNBC) treatment market all predict a sustainable growth oner the next several years...

Previous 10 Next 10